HIGHLANDS RANCH, CO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

CalNutri, Inc., a leading innovator in CPG commercialization, today announced the launch of Accelerate!, designed to empower emerging brands in the CPG space aligned with health, sustainability, and ...

Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non-hormonaltopical cream shown in clinical studies to increase genital ...

Quoting a reply he received from the Union ministry of rural development on unstarred questions regarding the scheme, the MP said that in 2024-25 only 2,191 households have been provided 100 days of ...

Pop star Selena Gomez's "Rare Beauty" comes with a little label that says "Made in Korea," one of hundreds of clients who ...

Supported by Wise Equity, NTC expands its portfolio in the glaucoma segment strengthening its competitive position in the ...

Novo Nordisk NVO is a dominant player in the cardiometabolic space, marketing its blockbuster semaglutide-based (GLP-1) drugs — Ozempic (for diabetes) and Wegovy (for obesity). Despite being NVO’s key ...

GLP, specifically GLP-1, and GIP act through complementary biological pathways that together can potentially improve glucose metabolism, energy balance, and weight regulation. By targeting both ...

At the forefront is the United States National Institutes of Health (NIH), contributing US$197.3 million, representing 27% of ...